The global pharmaceutical stability and storage services market was valued at USD 2.0 billion in 2025 and is projected to reach USD 2.2 billion in 2026 and USD 3.4 billion by 2033, expanding at a 6.5% CAGR from 2026 to 2033. North America accounted for the largest revenue share at 40.1% in 2025, while Asia Pacific is expected to record the fastest growth during the forecast period. Market expansion is being supported by increasingly complex drug development pipelines, growing production of biologics and advanced therapies, and regulatory requirements governing product shelf life, stability, and storage validation.

Market Snapshot

Grand View Research estimates that the pharmaceutical stability and storage services industry will continue expanding as pharmaceutical and biotechnology companies increasingly rely on specialized providers for validated stability programs, controlled storage environments, sample management, and related technical services.

What Is Driving Demand?

Several structural factors are contributing to the expansion of pharmaceutical stability and storage services. Pharmaceutical and biotechnology companies are outsourcing more stability and storage activities as drug pipelines become broader and product portfolios become more complex. The increasing development of biologics and advanced therapies is also generating demand for specialized temperature-controlled and validated storage environments.

Clinical trial activity is another important contributor. As development programs generate larger volumes of samples, sponsors require dependable storage capacity and systems that support sample tracking, retrieval, monitoring, and regulatory compliance. Demand is also increasing for cold and ultra-low-temperature storage, recurring commercial stability programs, and stability studies associated with packaging or formulation modifications.

Digital technologies are further changing service requirements. Providers are increasingly expected to offer digital monitoring, compliant sample-management systems, data visibility, and reliable documentation alongside physical storage and testing capabilities.

Download a free sample report or claim your copy of this full market intelligence report

Segment Performance

Small molecules remain the leading molecule segment. The small molecule segment accounted for 79.5% of the market in 2025, reflecting the substantial volume of conventional pharmaceutical products requiring stability evaluation and controlled storage throughout development and commercialization.

Stability testing represents the largest service segment. Stability testing captured 73.5% of the market in 2025, highlighting the central role of stability programs in determining product quality, shelf life, storage conditions, and regulatory readiness.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Regional Landscape

North America represented the largest regional market in 2025, accounting for 40.1% of global revenue. The U.S. held the largest country-level market share during the year.

Asia Pacific is expected to register the highest CAGR from 2026 to 2033. The region's growth trajectory is supported by expanding pharmaceutical and biotechnology activity and increasing requirements for specialized stability and storage infrastructure.

Market Dynamics: From Basic Storage to Integrated Stability Programs

The pharmaceutical stability and storage services industry is moving beyond standardized room-temperature programs toward a broader range of specialized requirements. Providers increasingly support refrigerated, frozen, ultra-low-temperature, humidity-controlled, photostability, freeze-thaw, and customized study conditions.

This diversification is increasing the importance of capabilities beyond physical storage. Sponsors are placing greater emphasis on technical consultation, protocol development, analytical integration, sample management, digital monitoring, and validated operating procedures.

The purchasing criteria for commercial stability and storage services are also evolving. Business continuity, redundancy, data integrity, response times, monitoring capabilities, deviation management, regulatory inspection readiness, and the ability to accommodate additional samples are becoming important considerations alongside pricing.

Competitive Structure and Service Differentiation

The competitive environment includes both globally integrated laboratory organizations and specialized stability and storage providers.

Integrated organizations can leverage bundled services, cross-selling opportunities, and end-to-end management of stability programs. Specialized providers, meanwhile, can differentiate through dedicated storage capacity, flexible operating models, customized environmental conditions, and faster project onboarding.

Facility location is also becoming strategically important. Developing storage and stability infrastructure close to major pharmaceutical and biotechnology clusters can reduce transportation risks and improve access to samples. As a result, providers are increasingly focusing on technical expertise, scalable capacity, digital transparency, operational reliability, and flexible commercial models.

Companies Profiled

The pharmaceutical stability and storage services market study profiles the following companies:

• Catalent, Inc.
• Almac Group
• Charles River Laboratories
• Eurofins Scientific
• Intertek Group plc
• Lucideon Limited
• Alcami Corporation
• Element Materials Technology
• BioLife Solutions Inc.
• Q1 Scientific

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• S. Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.